Dr. Layne is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2121 Santa Monica Blvd
Santa Monica, CA 90404Phone+1 310-453-1324Fax+1 424-212-5921
Summary
- Scott P Layne MD FACP FIDSA is a physician-scientist known for interdisciplinary work in applied virology, large-scale laboratory technologies, biological security policy and epidemiologic analysis. He has over 60 publications (including books, patents and government reports) with many technical publications appearing in the Proceedings of the National Academy of Science, Nature and Science.
Throughout the pandemic, as a practicing infectious disease physician, Dr. Layne has cared for over 1000 patients who were hospitalized for acute SARS-CoV-2 infections and life-threatening COVID-19. He has organized major scientific studies to understand how COVID-19 attacks and destroys human lungs and also authored major publications on topics pertaining to molecular pathogenesis of COVID-19 and needs for global surveillance of SARS-CoV-2 variants.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Infectious Disease, 1994 - 1996- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1992 - 1994
Loma Linda University Health Education ConsortiumInternship, Transitional Year, 1980 - 1981
University of California (San Francisco)Residency, Anesthesiology, 1980 - 1980
Case Western Reserve University School of MedicineClass of 1980
Certifications & Licensure
CA State Medical License 1981 - 2025
NM State Medical License 1983 - 2020- American Board of Internal Medicine Infectious Disease
- National Board of Physicians and Surgeons Infectious Disease
- National Board of Physicians and Surgeons Internal Medicine
Publications & Presentations
PubMed
- 60 citationsPandemic Influenza: An Inconvenient MutationScott P. Layne, Arnold S. Monto, Jeffery K. Taubenberger
Science. 2009-03-20 - 27 citationsHuman influenza surveillance: the demand to expand.Scott P. Layne
Emerging Infectious Diseases. 2006-04-01 - 29 citationsA global lab against influenza.Scott P. Layne, Tony J. Beugelsdijk, C. Kumar N. Patel, Jeffery K. Taubenberger, Nancy J. Cox
Science. 2001-09-07
Journal Articles
- Lung epithelial and endothelial damage, loss of tissue repair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19Felice D'Agnillo1, Kathie-Anne Walters, Yongli Xiao, et. al., Science Translational Medicine, 10/10/2021
- Increasing threats from SARS-CoV-2 variants: Time to establish global surveillanceScott P. Layne, Jeffery K. Taubenberger, Science Translational Medicine, 7/7/2021
- New coronavirus outbreak: Framing questions for pandemic preventionScott P. Layne, James M. Hyman, David M. Morens, Jeffery K. Taubenberger, Science Translational Medicine, 3/11/2020
Press Mentions
Recent Advances in Pathophysiology, Drug Development and Future Perspectives of SARS-CoV-2September 22nd, 2020
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
